Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
2340
Trial Sponsor
Clinical Trial Start Date
2007
0Primary Completion Date
2008
0Study Completion Date
2008
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Biological0
Interventional Trial Phase
Phase 30
Official Name
A Phase 3b, Open-Label, Single-Group Immunogenicity and Safety Study of Topical Recombinant Thrombin (rThrombin) in Surgical Hemostasis0
Last Updated
January 13, 2012
0Allocation Type
Non-Randomized0
Intervention Model
Single Group Assignment0
Masking Type
None (Open Label)0
Other attributes
Intervention Treatment
rThrombin0
Study summary
The purpose of this study is to evaluate the safety and immune system response to recombinant thrombin when used to control bleeding in spinal and vascular surgery.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
